Zantac lawsuit drop ‘not as significant as it appears’ for GSK stock, analysts say
August 17, 2022 at 07:09 AM EDT
The withdrawal of a plaintiff in GSK's first Zantac lawsuit but may not be “as significant as it appears”, say analysts from RBC Europe.
